
ISRG
Intuitive Surgical Inc.
Company Overview
| Mkt Cap | $159.93B | Price | $496.73 |
| Volume | 2.13M | Change | -1.49% |
| P/E Ratio | 68.9 | Open | $502.00 |
| Revenue | $8.4B | Prev Close | $504.22 |
| Net Income | $2.3B | 52W Range | $425.00 - $609.08 |
| Div Yield | N/A | Target | $625.62 |
| Overall | 32 | Value | 25 |
| Quality | 57 | Technical | 16 |
No chart data available
About Intuitive Surgical Inc.
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.
Latest News
Netflix, Cisco, ISRG, Visa, P&G Trending With Analysts
Barclays Remains a Buy on Intuitive Surgical (ISRG)
Analysts Conflicted on These Healthcare Names: Intuitive Surgical (ISRG) and Abbott Laboratories (ABT)
Intuitive Surgical Earnings Call: Growth Surges, Margins Pinched
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Corcept Therapeutics (CORT), Intuitive Surgical (ISRG) and Vertex Pharmaceuticals (VRTX)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ISRG | $496.73 | -1.5% | 2.13M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |